Maturation-Induced Cloaking of Neutralization Epitopes on HIV-1 Particles

English version České info

To become infectious, HIV-1 particles undergo a maturation process involving proteolytic cleavage of the Gag and Gag-Pol polyproteins. Immature particles contain a highly stable spherical Gag lattice and are impaired for fusion with target cells. The fusion impairment is relieved by truncation of the gp41 cytoplasmic tail (CT), indicating that an interaction between the immature viral core and gp41 within the particle represses HIV-1 fusion by an unknown mechanism. We hypothesized that the conformation of Env on the viral surface is regulated allosterically by interactions with the HIV-1 core during particle maturation. To test this, we quantified the binding of a panel of monoclonal antibodies to mature and immature HIV-1 particles by immunofluorescence imaging. Surprisingly, immature particles exhibited markedly enhanced binding of several gp41-specific antibodies, including two that recognize the membrane proximal external region (MPER) and neutralize diverse HIV-1 strains. Several of the differences in epitope exposure on mature and immature particles were abolished by truncation of the gp41 CT, thus linking the immature HIV-1 fusion defect with altered Env conformation. Our results suggest that perturbation of fusion-dependent Env conformational changes contributes to the impaired fusion of immature particles. Masking of neutralization-sensitive epitopes during particle maturation may contribute to HIV-1 immune evasion and has practical implications for vaccine strategies targeting the gp41 MPER.

Vyšlo v časopise: Maturation-Induced Cloaking of Neutralization Epitopes on HIV-1 Particles. PLoS Pathog 7(9): e32767. doi:10.1371/journal.ppat.1002234
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002234

Souhrn

Zdroje

1. HoxieJA 2010 Toward an antibody-based HIV-1 vaccine. Annu Rev Med 61 135 152

2. HunterESwanstromR 1990 Retrovirus envelope glycoproteins. Curr Top Microbiol Immunol 157 187 253

3. LodgeRLalondeJPLemayGCohenEA 1997 The membrane-proximal intracytoplasmic tyrosine residue of HIV-1 envelope glycoprotein is critical for basolateral targeting of viral budding in MDCK cells. EMBO J 16 695 705

4. RowellJFStanhopePESilicianoRF 1995 Endocytosis of endogenously synthesized HIV-1 envelope protein. Mechanism and role in processing for association with class II MHC. J Immunol 155 473 488

5. EganMACarruthLMRowellJFYuXSilicianoRF 1996 Human immunodeficiency virus type 1 envelope protein endocytosis mediated by a highly conserved intrinsic internalization signal in the cytoplasmic domain of gp41 is suppressed in the presence of the Pr55gag precursor protein. J Virol 70 6547 6556

6. FreedEOMartinMA 1996 Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J Virol 70 341 351

7. FreedEOMartinMA 1995 Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J Virol 69 1984 1989

8. WymaDJKotovAAikenC 2000 Evidence for a stable interaction of gp41 with Pr55(Gag) in immature human immunodeficiency virus type 1 particles. J Virol 74 9381 9387

9. CossonP 1996 Direct interaction between the envelope and matrix proteins of HIV-1. EMBO J 15 5783 5788

10. VogtVM 1996 Proteolytic processing and particle maturation. Curr Top Microbiol Immunol 214 95 131

11. WymaDJJiangJShiJZhouJLinebergerJE 2004 Coupling of human immunodeficiency virus type 1 fusion to virion maturation: a novel role of the gp41 cytoplasmic tail. J Virol 78 3429 3435

12. JiangJAikenC 2007 Maturation-dependent human immunodeficiency virus type 1 particle fusion requires a carboxyl-terminal region of the gp41 cytoplasmic tail. J Virol 81 9999 10008

13. MurakamiTAblanSFreedEOTanakaY 2004 Regulation of human immunodeficiency virus type 1 Env-mediated membrane fusion by viral protease activity. J Virol 78 1026 1031

14. KolNShiYTsvitovMBarlamDShneckRZ 2007 A stiffness switch in human immunodeficiency virus. Biophys J 92 1777 1783

15. EdwardsTGWyssSReevesJDZolla-PaznerSHoxieJA 2002 Truncation of the cytoplasmic domain induces exposure of conserved regions in the ectodomain of human immunodeficiency virus type 1 envelope protein. J Virol 76 2683 2691

16. SpiesCPRitterGDJrMulliganMJCompansRW 1994 Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters the conformation of the external domain. J Virol 68 585 591

17. MulliganMJYamshchikovGVRitterGDJrGaoFJinMJ 1992 Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in selected cell types. J Virol 66 3971 3975

18. ZhuPChertovaEBessJJrLifsonJDArthurLO 2003 Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions. Proc Natl Acad Sci U S A 100 15812 15817

19. TrkolaAPurtscherMMusterTBallaunCBuchacherA 1996 Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J Virol 70 1100 1108

20. HammondsJChenXDingLFoutsTDe VicoA 2003 Gp120 stability on HIV-1 virions and Gag-Env pseudovirions is enhanced by an uncleaved Gag core. Virology 314 636 649

21. RizzutoCDWyattRHernandez-RamosNSunYKwongPD 1998 A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 280 1949 1953

22. SullivanNSunYSattentauQThaliMWuD 1998 CD4-Induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization. J Virol 72 4694 4703

23. ChenCHGreenbergMLBolognesiDPMatthewsTJ 2000 Monoclonal antibodies that bind to the core of fusion-active glycoprotein 41. AIDS Res Hum Retroviruses 16 2037 2041

24. DimitrovASLouisJMBewleyCACloreGMBlumenthalR 2005 Conformational changes in HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion and inactivation. Biochemistry 44 12471 12479

25. JiangJAikenC 2006 Maturation of the viral core enhances the fusion of HIV-1 particles with primary human T cells and monocyte-derived macrophages. Virology 346 460 468

26. McDonaldDVodickaMALuceroGSvitkinaTMBorisyGG 2002 Visualization of the intracellular behavior of HIV in living cells. J Cell Biol 159 441 452

27. ChenCOkayamaH 1987 High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7 2745 2752

28. WehrlyKChesebroB 1997 p24 antigen capture assay for quantification of human immunodeficiency virus using readily available inexpensive reagents. Methods 12 288 293

29. HicarMDChenXBrineyBHammondsJWangJJ 2010 Pseudovirion particles bearing native HIV envelope trimers facilitate a novel method for generating human neutralizing monoclonal antibodies against HIV. J Acquir Immune Defic Syndr 54 223 235